STOK offering history
Every offering-related filing in Stoke Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 615 filings back to Nov 24, 2014.
| Date | Filing | What it means | |
|---|---|---|---|
| Aug 3, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 18, 2026 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Jul 11, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 9, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Oct 9, 2024 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Jun 20, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 13, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Mar 28, 2024 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Mar 28, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 26, 2024 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 31, 2022 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 20, 2022 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Nov 20, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 18, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 20, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jul 10, 2020 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jun 19, 2019 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Jun 18, 2019 | S-1MEF → | REGISTERED | S-1MEF registration — capacity to sell shares, not a sale yet |
| Jun 18, 2019 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 12, 2019 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Jun 7, 2019 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| May 23, 2019 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
STOK offering FAQ
When did STOK last execute an offering?
Per SEC filings, Stoke Therapeutics, Inc.'s most recent priced offering document is a 424B5 filed 2026-08-03. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did STOK last announce or register an offering?
The most recent registration is a S-3ASR filed 2026-03-18. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.